Implantable Cardiac Device PVC Detection via Morphology Metrics
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cardiac monitoring devices face challenges in differentiating premature ventricular contractions (PVCs) from premature atrial contractions (PACs) using a single ECG lead, especially in implantable medical devices with limited processing power, which can lead to inaccurate heart rate turbulence (HRT) measurements and confounded diagnostic results.
Innovation Solution
An implantable medical device (IMD) is designed to detect PVCs by analyzing R-wave intervals and morphology-related metrics, such as amplitude and area under the R-wave, to distinguish PVCs from PACs, allowing for reliable HRT monitoring and alert generation or therapeutic adjustments without requiring high processing burdens.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If complex algorithms are used to differentiate PVCs from PACs, then measurement precision is improved, but device complexity increases and processing power requirements exceed implantable device capabilities
Solution Approach 1:
The patent segments the ECG signal analysis into distinct morphological features (amplitude, area under the curve, duration) that can be independently calculated and evaluated. This segmentation allows the device to assess multiple simple parameters rather than requiring one complex algorithm, thereby maintaining measurement precision while reducing processing requirements suitable for implantable devices.
Solution Approach 2:
The patent transforms the complex differentiation problem into comparisons of specific measurable parameters (amplitude ratios, area ratios, duration ratios) between the premature beat and preceding normal beats. By changing the approach from pattern recognition to parameter comparison, the system achieves accurate PVC/PAC differentiation with simplified calculations appropriate for implantable device processors.
2Measurement precision
If multiple ECG leads are used to improve PVC detection accuracy, then measurement precision is improved, but device complexity and implantation invasiveness increase
Solution Approach 1:
The patent applies partial action by using only the essential morphological parameters needed for differentiation rather than requiring complete multi-lead ECG information. By calculating amplitude, area, and duration from a single lead and comparing these partial measurements against threshold criteria, the system achieves sufficient detection accuracy without the complexity of multiple leads.
Solution Approach 2:
The patent changes the approach from spatial analysis (multiple leads) to temporal and morphological analysis (single lead with multiple parameters). By measuring amplitude, area under the curve, and duration of the same single-lead ECG signal, the system extracts multiple discriminatory parameters that replace the need for multiple spatial perspectives provided by additional leads.
3Measurement precision
If morphology-related metrics are calculated for every premature contraction, then measurement precision is improved, but use of energy increases beyond implantable device capabilities
Solution Approach 1:
The patent applies partial action by performing full morphological metric calculations only for premature contractions that meet preliminary screening criteria (such as coupling interval thresholds). By partially evaluating all premature beats and fully analyzing only those likely to be PVCs, the system maintains HRT measurement accuracy while significantly reducing the average energy consumption compared to analyzing every premature contraction in detail.
Solution Approach 2:
The patent performs preliminary screening of premature contractions using simple criteria (coupling interval comparison, basic amplitude threshold) before committing to energy-intensive morphological measurements. This preliminary action filters out obvious PACs and other non-PVC events, ensuring that full metric calculations are performed only when necessary, thereby optimizing the balance between measurement precision and energy consumption.
Data Source
AI summary
A medical device system and method for monitoring a cardiac signal in a patient senses ventricular R-waves and computes a morphology metric of an R-wave and a corresponding preceding morphology metric of a preceding R-wave. One of a difference and a ratio of the R-wave morphology metric and the preceding R-wave morphology metric is compared to an established detection threshold for discriminating premature ventricular contractions from premature atrial contractions. A cardiac signal measurement is computed from the sensed R-waves in response to detecting a premature ventricular comparison based on the comparison.